Perspective Therapeutics (CATX) Current Leases (2019 - 2026)

Perspective Therapeutics has disclosed Current Leases across 8 years of filings, most recently posting $1.1 million for Q1 2026.

• Current Leases for Q1 2026 came in at $1.1 million, up 9.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (up 9.08% YoY), and the FY2025 annual result was $623000.0, down 34.9% from the prior year.
• Current Leases came in at $1.1 million for Q1 2026 at Perspective Therapeutics, up from $623000.0 in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.1 million in Q1 2026 to a low of $46000.0 in Q4 2023.
• The 5-year median for Current Leases is $458000.0 (2023), against an average of $538500.0.
• Peak annual rise in Current Leases reached 1980.43% in 2024, while the deepest fall reached 54.29% in 2024.
• Perspective Therapeutics' Current Leases stood at $272000.0 in 2022, then sank by 83.09% to $46000.0 in 2023, then jumped by 1980.43% to $957000.0 in 2024, then tumbled by 34.9% to $623000.0 in 2025, then soared by 71.59% to $1.1 million in 2026.
• The last three Current Leases figures came in at $1.1 million (Q1 2026), $623000.0 (Q4 2025), and $704000.0 (Q3 2025), per Business Quant data.